You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Enhanced Treatment Management of Opioid-Dependence in an Office-Based Setting

    SBC: MedicaSafe Inc            Topic: NIDA

    PROJECT SUMMARY ABSTRACT Opioid use disorder is the leading cause of accidental death in the USwith overlethal drug overdoses inSAMHSA estimates thatmillion Americans misuse prescription opioids for non medical purposes annuallyPublic health officials and policymakers have acknowledged the urgent need for innovative approaches to the treatment of those with opioid use disorderin spite of thisthe a ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  2. Tau oligomer platform validation using lead series candidate in htau mice

    SBC: OLIGOMERIX INC            Topic: NIA

    TITLETau oligomer platform validation using lead series candidate in htau mice PROJECT SUMMARYSBIR Funding OpportunityAdvancing Research on Alzheimerandapos s DiseaseADand Alzheimerandapos s Disease Related DementiasADRDRRPASThe long term goal of this program is to develop a disease modifyingsmall molecule drug for Alzheimer s diseaseADand related tauopathiesThere is a critical unmet need for a di ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  3. Development and validation of therapy for mucopolysaccharidosis III

    SBC: Phoenix Nest Inc.            Topic: 103

    Project Summary Sanfilippo disease (mucopolysaccharidosis type III; MPS III) is a devastating neurodegenerative lysosomal storage disorder of childhood whose pathologic features are neurologic: slowing of development, severe behavioral problems, progressive cognitive decline, dementia, and decline in motor skills leading to immobility, unresponsiveness, and death. We have focused on MPS IIID cause ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  4. Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction

    SBC: Recursion Pharmaceuticals, LLC            Topic: NIA

    DESCRIPTION (provided by applicant): Chronic diseases of aging account for a significant proportion of healthcare spending and result in a painful and limiting existence for many tens of millions of Americans and hundreds of millions of people around the world. Recursion Pharmaceuticals has developed a drug discovery platform that re-purposes known drugs for the treatment of such diseases. The pla ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  5. SOURCE APPROVAL REQUEST (SAR) FOR MULTIPLE ITEMS and First Article

    SBC: NDI ENGINEERING COMPANY            Topic: DLA171002

    This proposal seeks NDI Engineering Company (CAGE code: 4X596) to become approved as apotential source of supply to DLA for the MK 2 Nose Gear Launch Shaft Assembly, NAVAIRpart number 511224-1; Shaft, Shouldered, NSN 3040-00-224-9019. In Phase I, NDIEngineering Company submitted one a Source Approval Request (SAR) for the manufacturingof the Shaft Assembly defined as NAVAIR part number 511224-1. I ...

    SBIR Phase II 2018 Department of DefenseDefense Logistics Agency
  6. Reverse Engineering Technical Data Packages for Development of Alternate Sources of Supply for DLA NSNs

    SBC: Brighton Cromwell, LLC            Topic: DLA171002

    In Phase 1, we obtained samples through the RPPOB process, performed due diligence, reverse engineered, created engineering drawings, performed positive material identifications, assigned proper quality control documentation, and all pertinent technical activities to complete a technical data package in accordance with the DLA requirements and submit a SAR for evaluation and acceptance. In this pr ...

    SBIR Phase II 2018 Department of DefenseDefense Logistics Agency
  7. Reverse Engineering Technical Data Packages for Development of Alternate Sources of Supply for DLA NSNs

    SBC: Brighton Cromwell, LLC            Topic: DLA171002

    This proposal introduces an approach from Brighton Cromwell to Improve product availability and increase competition through the development of Small Business eligible manufacturing utilizing the DLA’s Land and Maritime (L&M) Limited Source National Stock Number (NSN) List. The list contains NSNs with an Annual Demand Value (ADV) >$10K currently sourced with only 1-2 manufacturers. We are offeri ...

    SBIR Phase II 2018 Department of DefenseDefense Logistics Agency
  8. Tamper Resistant/Anti-Counterfeit Package Labeling

    SBC: UTILITY DEVELOPMENT CORP            Topic: DLA163003

    The objective will becontinue the progress made in Phase I program for anti-counterfeiting label/tape solutions which are easy to deploy through the existing DLA supply chain. We willdemonstratethe technologies withtamper and counterfeit detection capabilities. A comprehensive report will be submitted that will include the results of the demonstration, describes how the technology might be impleme ...

    SBIR Phase II 2018 Department of DefenseDefense Logistics Agency
  9. High-throughput nanoMEA-based Proarrhythmia Assay

    SBC: CURI BIO, INC.            Topic: NHLBI

    PROJECT SUMMARY Failure of new drugs at late stages of development is an extremely costly event commonly associated with the detection of unexpected arrhythmogenic properties in novel drugs Undetected arrhythmia inducing effects are also a common reason for drug withdrawal from the market As a result the FDA now mandates that all new drugs be tested for potential arrhythmogenic properties which ha ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  10. STEM Interactive Digital Tool to Educate and Promote Hearing Health and Science for 4th to 7th Grade

    SBC: CREARE LLC            Topic: 500

    PROJECT SUMMARY ABSTRACT The National Research Council recognizes that serious computer games can support new inquiry based approaches to science instructionproviding virtual laboratories or field learning experiences that overcome practical and logistical constraints to student investigationsWith the nationally recognized need to encourage and enhance education in the ScienceTechnologyEngineering ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government